千葉大学大学院医学研究院泌尿器科学・千葉大学医学部附属病院泌尿器科
English サイトマップ HOME
入局・研修をご希望の方 泌尿器科学教室について 患者様用当科診療案内
泌尿器科学教室について
教室概要
研究業績
2004年度教室業績
2005年度教室業績
2006年度教室業績
2007年度教室業績
2008年度教室業績
2009年度教室業績
2010年度教室業績
2011年度教室業績
2012年度教室業績
2013年度教室業績
2014年度教室業績
2015年度教室業績
学会賞・受賞報告
教室に関するお問い合わせ

共通メニュー
教室員紹介
関連病院紹介
泌尿器科学 同門会
教室主催の学会・研究会
千葉大学医学部
千葉大学附属病院
交通のご案内
入局・研修をご希望の方
泌尿器科学教室について
患者様用当科診療案内
HOME > 泌尿器科学教室について > 研究業績 > 2008年度教室業績
2008年度教室業績
英文原著
1 Kaneoya K, Ueda T, Suito H, Nanazawa Y, Tamaru J, Isobe K, Naya Y, Tobe T, Motoori K, Yamamoto S, Rubin GD, Minami M, Ito H.Functional computed tomography imaging of tumor-induced angiogenesis: preliminary results of new tracer kinetic modeling using a computer discretization approach.Radiat Med. 2008 May;26(4):213-221
2 Kawamura K, Suzuki H, Kamiya N, Imamoto T, Yano M, Miura J, Shimbo M, Suzuki N, Nakatsu H, Ichikawa T.Development of a new nomogram for predicting the probability of a positive initial prostate biopsy in Japanese patients with serum PSA levels less than 10 ng/mL. Int J Urol. 2008 May;15():598-603
3 Kamiya N, Suzuki H, Kawamura K, Imamoto T, Naya Y, Tochigi N, Kakuta Y, Yamaguchi K, Ishikura H, Ichikawa T.Neuroendocrine differentiation in stage D2 prostate cancers. Int J Urol. 2008 May;15(5):423-8
4 Imamoto T, Suzuki H, Yano M, Kawamura K, Kamiya N, Araki K, Komiya A, Nihei N, Naya Y, Ichikawa T.The role of testosterone in the pathogenesis of prostate cancer. Int J Urol. 2008 Jun;15(6):472-480
5 Fukasawa S, Kino M, Kobayashi M, Suzuki H, Komiya A, Imamoto T, Hirokawa Y, Shiraishi T, Takiguchi M, Ishida H, Shindo T, Seki N, Ichikawa T.Genetic changes in pT2 and pT3 prostate cancer detected by comparative genomic hybridization.Prostate Cancer Prostatic Dis. 2008 ;11(3):303-310
6 Suzuki H, Okihara K, Miyake H, Fujisawa M, Miyoshi S, Matsumoto T, Fujii M, Takihana Y, Usui T, Matsuda T, Ozono S, Kumon H, Ichikawa T, Miki T; Nonsteroidal Antiandrogen Sequential Alternation for Prostate Cancer Study Group.Alternative nonsteroidal antiandrogen therapy for advanced prostate cancer that relapsed after initial maximum androgen blockade.J Urol. 2008 Sep;180(3):921-7
7 Awa Y, Suzuki H, Hamano S, Okano T, Sakurayama Y, Ohki T, Egoshi K, Ota S, Mori I, Ichikawa T.Clinical effect of alpha 1D/A adrenoceptor inhibitor naftopidil on benign prostatic hyperplasia: an international prostate symptom score and King's Health Questionnaire assessment. Int J Urol. 2008 Aug;15():709-715
8 Suzuki H, Kamiya N, Imamoto T, Kawamura K, Yano M, Takano M, Utsumi T, Naya Y, Ichikawa T.Current topics and perspectives relating to hormone therapy for prostate cancer.Int J Clin Oncol. 2008 Oct;13(5):401-410
9 Kobayashi M, Ishida H, Shindo T, Niwa S, Kino M, Kawamura K, Kamiya N, Imamoto T, Suzuki H, Hirokawa Y, Shiraishi T, Tanizawa T, Nakatani Y, Ichikawa T.Molecular analysis of multifocal prostate cancer by comparative genomic hybridization.Prostate 2008 39783;68(16):1715-1724
10 Kobayashi M, Naya Y, Kino M, Awa Y, Nagata M, Suzuki H, Yamaguchi K, Nozumi K, Ichikawa T.Low dose tamsulosin for stone expulsion after extracorporeal shock wave lithotripsy: efficacy in Japanese male patients with ureteral stone. Int J Urol. 2008 Jun;15(6):495-8
11 Watanabe M, Hirokawa Y, Tsuji M, Yanagawa M, Murata T, Suzuki H, Ichikawa T, Katoh T, Sugimura Y, Shiraishi T.Lack of involvement of the GNAS1 T393C polymorphism in prostate cancer risk in a Japanese population.Anticancer Res. 2008 Nov-Dec;28(6A):3711-3716
12 Imamoto T, Suzuki H, Yano M, Kawamura K, Kamiya N, Araki K, Komiya A, Naya Y, Shiraishi T, Ichikawa T.Does presence of prostate cancer affect serum testosterone levels in clinically localized prostate cancer patients?Prostate Cancer Prostatic Dis. 2009 ;12(1):78-82
13 Kojima S, Inahara M, Suzuki H, Ichikawa T, Furuya Y.Implications of insulin-like growth factor-I for prostate cancer therapies.Int J Urol. 2009 Feb;16(2):161-167


一つ前のページへ戻る このページの先頭へ HOMEに戻る
copyright(C). Department of Urology. Graduate School of Medicine. Chiba University. All Rights Reserved.